1. Home
  2. MBOT vs BIOA Comparison

MBOT vs BIOA Comparison

Compare MBOT & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • BIOA
  • Stock Information
  • Founded
  • MBOT 2010
  • BIOA 2015
  • Country
  • MBOT United States
  • BIOA United States
  • Employees
  • MBOT N/A
  • BIOA 64
  • Industry
  • MBOT Medical/Dental Instruments
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBOT Health Care
  • BIOA Health Care
  • Exchange
  • MBOT Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • MBOT 184.8M
  • BIOA 175.7M
  • IPO Year
  • MBOT N/A
  • BIOA 2024
  • Fundamental
  • Price
  • MBOT $3.34
  • BIOA $5.07
  • Analyst Decision
  • MBOT Strong Buy
  • BIOA Hold
  • Analyst Count
  • MBOT 1
  • BIOA 4
  • Target Price
  • MBOT $12.00
  • BIOA $5.67
  • AVG Volume (30 Days)
  • MBOT 7.2M
  • BIOA 180.2K
  • Earning Date
  • MBOT 11-12-2025
  • BIOA 11-06-2025
  • Dividend Yield
  • MBOT N/A
  • BIOA N/A
  • EPS Growth
  • MBOT N/A
  • BIOA N/A
  • EPS
  • MBOT N/A
  • BIOA N/A
  • Revenue
  • MBOT N/A
  • BIOA $3,863,000.00
  • Revenue This Year
  • MBOT N/A
  • BIOA N/A
  • Revenue Next Year
  • MBOT $728.02
  • BIOA N/A
  • P/E Ratio
  • MBOT N/A
  • BIOA N/A
  • Revenue Growth
  • MBOT N/A
  • BIOA N/A
  • 52 Week Low
  • MBOT $0.85
  • BIOA $2.88
  • 52 Week High
  • MBOT $4.67
  • BIOA $26.62
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 47.14
  • BIOA 61.77
  • Support Level
  • MBOT $3.16
  • BIOA $4.68
  • Resistance Level
  • MBOT $4.25
  • BIOA $5.11
  • Average True Range (ATR)
  • MBOT 0.40
  • BIOA 0.23
  • MACD
  • MBOT -0.10
  • BIOA 0.01
  • Stochastic Oscillator
  • MBOT 11.59
  • BIOA 92.86

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: